Profile
Aaron Tward is the founder of Affinia Therapeutics, Inc., founded in 2019.
Dr. Tward currently holds the positions of Associate Professor at The University of California, San Francisco since 2022 and Chief Scientific Officer at Akouos, Inc. since 2022.
Dr. Tward earned a doctorate degree from The University of California, San Francisco.
Aaron Tward active positions
| Companies | Position | Start |
|---|---|---|
| AKOUOS | Chief Tech/Sci/R&D Officer | 2022-03-09 |
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2022-02-28 |
Former positions of Aaron Tward
| Companies | Position | End |
|---|---|---|
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Founder | - |
Training of Aaron Tward
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akouos, Inc.
Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
- Stock Market
- Insiders
- Aaron Tward
















